By inhibiting oxidative stress [107] and activating HSCs, CGAs protect against CCL4-induced liver fibrosis both in vitro and in vivo by producing vascular endothelial growth factor (VEGF) and TGF-β1. Here, TGFB1 is linked to Hepatic fibrosis.